Search for Clinical Trial Results

Sponsored By

Erdheim-Chester Disease - 8 Studies Found

Status Study
Terminated Study Name: Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease
Condition: Erdheim-Chester Disease
Date: 2012-11-12
Interventions: Drug: Tocilizumab Other Names:
  • Ro-Actemra
  • Actemra
Recruiting Study Name: Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease
Condition: Erdheim-Chester Disease
Date: 2014-03-15
Suspended Study Name: Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
Condition: BRAF V600E Mutation
Date: 2014-11-01
Interventions:
  • Drug: Dabrafenib Mesylate Desc
Recruiting Study Name: A Study of Lenalidomide for Adult Histiocyte Disorders
Condition:
  • Langerhans Cell Histiocytosis (LCH)
  • Histiocytoses Erdheim-chester Dise
    Date: 2015-08-12
    Interventions: Drug: Lenalidomide Other Name: Revlimid
Recruiting Study Name: Biomarker for Farber Disease
Condition:
  • Farber's Lipogranulomatosis
  • Ceramidase Deficiency
  • Date: 2014-10-23
Recruiting Study Name: Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement
Condition:
  • Erdheim-Chester Disease
  • Langerhans Cell Histiocytosis
  • Date: 2015-11-17
    Interventions:
    • Radiation: F-choline PET Scan
    • Device: FDG-
Recruiting Study Name: A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis
Condition: Histiocytosis
Date: 2017-04-11
Interventions:
  • Behavioral: Trail Making Test, Parts A & B

Recruiting Study Name: International Rare Histiocytic Disorders Registry (IRHDR)
Condition:
  • Rare Histiocytic Disorders (RHDs)
  • Juvenile Xanthogranuloma (JXG)